| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 230.78B | 236.28B | 228.42B | 221.08B | 199.18B | 182.31B |
| Gross Profit | 61.86B | 64.35B | 58.63B | 56.25B | 49.75B | 44.61B |
| EBITDA | 21.05B | 22.07B | 21.15B | 19.91B | 14.11B | 13.56B |
| Net Income | 12.27B | 12.64B | 13.16B | 10.58B | 7.90B | 6.71B |
Balance Sheet | ||||||
| Total Assets | 196.97B | 205.65B | 204.98B | 206.88B | 177.25B | 169.21B |
| Cash, Cash Equivalents and Short-Term Investments | 41.45B | 37.20B | 40.11B | 40.15B | 31.41B | 36.45B |
| Total Debt | 15.37B | 21.32B | 21.28B | 21.52B | 15.52B | 15.80B |
| Total Liabilities | 88.48B | 85.64B | 91.53B | 102.95B | 94.46B | 86.69B |
| Stockholders Equity | 108.32B | 119.84B | 113.29B | 103.77B | 82.60B | 82.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.80B | 6.17B | 11.81B | 4.34B | 7.12B |
| Operating Cash Flow | 0.00 | 10.01B | 10.97B | 15.64B | 7.51B | 9.35B |
| Investing Cash Flow | 0.00 | -3.16B | -3.75B | -16.89B | -1.57B | 13.00M |
| Financing Cash Flow | 0.00 | -9.90B | -6.79B | 9.51B | -10.96B | -9.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥42.46B | 8.17 | ― | 3.74% | 4.73% | 17.57% | |
71 Outperform | ¥31.93B | 8.57 | ― | 3.59% | 6.27% | 28.43% | |
68 Neutral | ¥123.53B | 10.61 | 12.89% | 3.40% | 3.44% | -3.09% | |
68 Neutral | ¥5.62B | 7.04 | ― | 4.13% | 2.80% | 4.60% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥466.47B | -31.80 | 1.44% | 4.80% | 0.40% | 306.91% | |
55 Neutral | ¥98.42B | 43.49 | ― | 3.53% | -3.19% | -4.14% |